<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
ACCOMPANYING FINANCIAL STATEMENTS AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE
TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<CIK>                         095676
<NAME>                        Meridian Medical Technologies, Inc.
<MULTIPLIER>                  1,000
<CURRENCY>                    US Dollars

<S>                             <C>
<PERIOD-TYPE>                                               9-MOS
<FISCAL-YEAR-END>                                     JUL-31-2000
<PERIOD-START>                                         AUG-1-1999
<PERIOD-END>                                          APR-30-2000
<EXCHANGE-RATE>                                             1.000
<CASH>                                                        445
<SECURITIES>                                                    0
<RECEIVABLES>                                               7,624
<ALLOWANCES>                                                 (570)
<INVENTORY>                                                10,204
<CURRENT-ASSETS>                                           20,374
<PP&E>                                                     22,673
<DEPRECIATION>                                             (6,989)
<TOTAL-ASSETS>                                             46,551
<CURRENT-LIABILITIES>                                      13,968
<BONDS>                                                    17,013
                                           0
                                                     0
<COMMON>                                                      299
<OTHER-SE>                                                 12,685
<TOTAL-LIABILITY-AND-EQUITY>                               46,551
<SALES>                                                    37,889
<TOTAL-REVENUES>                                           37,889
<CGS>                                                      22,970
<TOTAL-COSTS>                                              22,970
<OTHER-EXPENSES>                                           10,523
<LOSS-PROVISION>                                                0
<INTEREST-EXPENSE>                                          2,469
<INCOME-PRETAX>                                             1,927
<INCOME-TAX>                                                  675
<INCOME-CONTINUING>                                         1,252
<DISCONTINUED>                                                  0
<EXTRAORDINARY>                                                 0
<CHANGES>                                                       0
<NET-INCOME>                                                 1252
<EPS-BASIC>                                                  0.42
<EPS-DILUTED>                                                0.39


</TABLE>



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission